Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessing the Diagnostic Yield of Targeted Next-Generation Sequencing for Melanoma and Gastrointestinal Tumors.

The Journal of molecular diagnostics : JMD - 1 Apr 2020

Garg Swati, Grenier Sylvie, Misyura Maksym, Sukhai Mahadeo A, Thomas Mariam, Kamel-Reid Suzanne, Stockley Tracy

Abstract excerpt

A common rationale in molecular diagnostic laboratories is that implementation of next-generation sequencing (NGS) enables simultaneous multigene testing, allowing increased information benefit compared with non-NGS assays. However, minimal published data exist to support this justification. The current study compared clinical diagnostic yield of TruSight Tumor 26 Sequencing Panel (TST26) in melanoma, colorectal...

Topics

Join the communities discussing this publication.

Biomarkers, Tumor
DNA Mutational Analysis
Gastrointestinal Neoplasms
High-Throughput Nucleotide Sequencing
Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Proto-Oncogene Proteins B-raf

Proto-Oncogene Proteins c-kit

Source

Identifiers

PMID: 32036084
DOI: 10.1016/j.jmoldx.2019.12.008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessing the Diagnostic Yield of Targeted Next-Generation Sequencing for Melanoma and Gastrointestinal Tumors.PMID 32036084Read ↗

Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.Semantic proximity Read ↗

Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel.Semantic proximity Read ↗

Comprehensive targeted next‐generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumorSemantic proximity Read ↗

Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing PanelSemantic proximity Read ↗

Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples.Semantic proximity Read ↗

Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.Semantic proximity Read ↗

Clinical Application of Next-Generation Sequencing-Based Panel to BRAF Wild-Type Advanced Melanoma Identifies Key Oncogenic Alterations and Therapeutic Strategies.Semantic proximity Read ↗

Improving care of melanoma patients through efficient, integrated cellular-molecular pathology workflows using tissue samples with low tumour nuclear content.Semantic proximity Read ↗

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNASemantic proximity Read ↗

Role and complexity of next-generation sequencing in melanoma.Semantic proximity Read ↗

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.Semantic proximity Read ↗

A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.